Etrasimod Arginine clinical trials

C5041034 - A Phase 1, Open-Label, Randomized, Single Dose, Crossover Study to Estimate the Relative Bioavailability of Etrasimod (PF-07915503) Mini Tablets in Water and 3 Food Vehicles Compared to the Etrasimod (PF-07915503) Clinical IR Tablets Under Fasted Conditions, and to Evaluate Mini Tablet Palatability in Healthy Adult Participants

This study looks at how a new medicine, etrasimod, is absorbed by the body. We're comparing different forms of the medicine in healthy adults to see which works best and is easiest to take, especially for conditions like ulcerative colitis.